 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE135820 |
Ovarian Cancer |
Development and validation of PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE) |
2019 |
Tissue |
Y |
4077 |
 |
|
GSE132342 |
Ovarian Cancer |
A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer |
2019 |
Tissue |
Y |
3769 |
|
|
E-MTAB-6691 |
Ovarian Cancer |
A microarray meta-dataset of ovarian cancer |
2018 |
Tissue |
N |
625 |
|
|
GSE13876 |
Ovarian Cancer |
Survival Related Profile, Pathways and Transcription Factors in Ovarian Cancer |
2008 |
Tissue |
N |
415 |
 |
|
GSE107460 |
Pregnancy |
Emory University African American Microbiome in Pregnancy Cohort |
2017 |
Blood |
N |
410 |
|
|
GSE59491 |
Pregnancy |
Maternal Whole Blood Gene Expression at 18 and 28 weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women |
2014 |
Blood |
N |
326 |
 |
|
GSE44001 |
Cervical Cancer |
Genetic profiling to predict recurrence of early cervical cancer |
2013 |
Tissue |
N |
300 |
|
|
GSE9891 |
Ovarian Cancer |
Expression profile of 285 ovarian tumour samples |
2007 |
Tissue |
N |
285 |
|
|
GSE32062 |
Ovarian Cancer |
Immune-activation as a therapeutic direction for patients with high-risk ovarian cancer based on gene expression signature (1) |
2011 |
Tissue |
N |
260 |
|
|
GSE26712 |
Ovarian Cancer |
A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer |
2011 |
Tissue |
N |
195 |
|
|
GSE20565 |
Ovarian Cancer |
Primary and secondary ovarian tumors |
2010 |
Tissue |
N |
172 |
|
|
GSE47856 |
Ovarian Cancer |
Expression data from cultured human ovarian carcinoma cell lines with and without Cisplatin treatment |
2015 |
Tissue |
N |
171 |
|
|
GSE17260 |
Ovarian Cancer |
Prediction of progression-free survival in patients with advanced-stage serous ovarian cancer |
2009 |
Tissue |
N |
110 |
|
|
GSE69207 |
Ovarian Cancer |
Gene expression data of ovarian cancer from Singapore |
2015 |
Tissue |
N |
100 |
|
|
E-MTAB-7083 |
Ovarian Cancer |
Transcriptional profiling of platinum sensitive and platinum resistant high grade serous ovarian cancer samples |
2018 |
Tissue |
N |
70 |
|
|
GSE66957 |
Ovarian Cancer |
Pathways of ovarian cancer development |
2015 |
Tissue |
N |
69 |
|
|
GSE18520 |
Ovarian Cancer |
Whole-genome oligonucleotide expression analysis of papillary serous ovarian adenocarcinomas |
2009 |
Tissue |
N |
63 |
|
|
GSE31245 |
Ovarian Cancer |
Unique gene expression profile based upon pathologic response in epithelial ovarian cancer |
2011 |
Tissue |
N |
58 |
|
|
GSE7410 |
Cervical Cancer |
Gene expression in early stage cervical cancer |
2007 |
Tissue |
N |
45 |
|
|
GSE7463 |
Ovarian Cancer |
Expression data from 43 Ovarian tumors |
2007 |
Tissue |
N |
43 |
|
|
GSE184904 |
Endometrial Cancer |
Diagnostic accuracy of liquid biopsy in endometrial cancer |
2021 |
Blood |
Y |
39 |
|
|
GSE19829 |
Ovarian Cancer |
A gene expression profile of BRCAness that is associated with outcome in ovarian cancer |
2010 |
Tissue |
N |
28 |
|
|
GSE55056 |
Ovarian Cancer |
RNA profiling from ovarian FFPE specimens (Nanostring) |
2014 |
Tissue |
Y |
24 |
|
|
GSE73168 |
Ovarian Cancer |
Gene expression profile of tumor cells from primary tumors, ascites and metastases of high grade serous ovarian cancer patients |
2015 |
Tissue |
N |
24 |
|
|
GSE29220 |
Ovarian Cancer |
Discovery of salivary transcriptomic biomarkers for ovarian cancer |
2011 |
Saliva |
N |
22 |
|
|
GSE71524 |
Ovarian Cancer |
Illumina HT-12 v4 expression array data for Ovarian Cancer Samples |
2015 |
Tissue |
N |
20 |
|
|
GSE44711 |
Preeclampsia |
Gene expression in Early-Onset Preeclampsia Placentas and Controls |
2013 |
Tissue |
N |
16 |
|
|
GSE73064 |
Ovarian Cancer |
Gene expression profile of tumor cells from primary tumors, ascites and metastases of high grade serous ovarian cancer patients |
2015 |
Tissue |
N |
15 |
|
|
GSE120196 |
Ovarian Cancer |
Identification of gene signature in microdissected omental adipose tissue from high grade serous ovarian cancer patients |
2018 |
Tissue |
N |
14 |
|
|
E-MTAB-9475 |
Cervical Cancer |
RNA microarray of human cervical cancer cell line HeLa treated with imatinib, mitoxantrone or mitoxantrone+imatinib combination against untreated controls |
2021 |
Tissue |
N |
11 |
|
|
GSE190688 |
Ovarian Cancer |
RNA sequencing of 6 HGSOC and 5 FTE |
2021 |
Tissue |
Y |
11 |
|
|
GSE18809 |
Pregnancy |
Differentially expressed mRNA transcripts in the placenta delivered by preterm versus term spontaneous labour |
2009 |
Tissue |
N |
10 |
|
|
GSE73091 |
Ovarian Cancer |
Gene expression profile of tumor cells from primary tumors, ascites and metastases of high grade serous ovarian cancer patients |
2015 |
Tissue |
N |
9 |
|
|
|
|
|
|
|
|
|